 Ocugen OCGN stock is falling hard on Friday after the FDA rejected its Emergency Use Authorization request for Covaxin. The post Ocugen Latest News: What OCGN Stock Investors Need to Know About the FDAs Covaxin Rejection appeared first on InvestorPlace. 